PRIMARY DOCUMENT

Company

Atara Biotherapeutics, Inc.

Filed

January 5, 2018

Accession Number

0001654954-18-000126

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →